Suppression of FoxO1 activity by long-chain fatty acyl analogs

Diabetes

Volumn 60, Issue 7, 2011, Pages 1872-1881

  Zatara, Ghadeer ^a   Hertz, Rachel ^a   Shaked, Maayan ^a   Mayorek, Nina ^a   Morad, Etedal ^a   Grad, Etty ^b   Cahan, Amos ^a   Danenberg, Haim D ^b   Unterman, Terry G ^c   Bar Tana, Jacob ^a  

^a HEBREW UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA,ALPHA' TETRAMETHYLHEXADECANEDIOIC ACID; C REACTIVE PROTEIN; CCAAT ENHANCER BINDING PROTEIN BETA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LONG CHAIN FATTY ACID; METFORMIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG; DICARBOXYLIC ACID; FORKHEAD TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; ENZYME ACTIVATION; INSULIN SENSITIVITY; MALE; MOUSE; NONHUMAN; NUCLEAR EXPORT SIGNAL; PRIORITY JOURNAL; ACUTE PHASE RESPONSE; ANIMAL; CELL STRAIN COS1; CELL STRAIN HEPG2; CERCOPITHECUS; DRUG EFFECT; GUINEA PIG; HUMAN; METABOLISM; PHYSIOLOGY; TRANSGENIC MOUSE;

ACUTE-PHASE REACTION; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; C-REACTIVE PROTEIN; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CERCOPITHECUS AETHIOPS; COS CELLS; DICARBOXYLIC ACIDS; FORKHEAD TRANSCRIPTION FACTORS; GUINEA PIGS; HEP G2 CELLS; HUMANS; INSULIN; MALE; METFORMIN; MICE; MICE, TRANSGENIC; STAT3 TRANSCRIPTION FACTOR;

EID: 80052098833     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-0248     Document Type: Article

References (50)

1. Cheng Z, White MF. Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models. Antioxid Redox Signal 2011;14:649-661
2. Samuel VT, Choi CS, Phillips TG, et al. Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action. Diabetes 2006;55:2042-2050 (Pubitemid 44509978)
3. Matsumoto M, Pocai A, Rossetti L, Depinho RA, Accili D. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metab 2007;6:208-216 (Pubitemid 47336849)
4. Bastie CC, Nahlé Z, McLoughlin T, et al. FoxO1 stimulates fatty acid uptake and oxidation in muscle cells through CD36-dependent and -independent mechanisms. J Biol Chem 2005;280:14222-14229 (Pubitemid 40517324)
5. Kamagate A, Qu S, Perdomo G, et al. FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice. J Clin Invest 2008;118: 2347-2364 (Pubitemid 351872351)
6. Altomonte J, Cong L, Harbaran S, et al. Foxo1 mediates insulin action on apoC-III and triglyceride metabolism. J Clin Invest 2004;114:1493-1503 (Pubitemid 40385579)
7. Kitamura T, Nakae J, Kitamura Y, et al. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic β cell growth. J Clin Invest 2002;110:1839-1847 (Pubitemid 36076491)
8. van der Vos KE, Coffer PJ. FOXO-binding partners: it takes two to tango. Oncogene 2008;27:2289-2299 (Pubitemid 351501780)
9. Kortylewski M, Feld F, Krüger KD, et al. Akt modulates STAT3-mediated gene expression through a FKHR (FOXO1a)-dependent mechanism. J Biol Chem 2003;278:5242-5249 (Pubitemid 36801037)
10. Ortiz-Muñoz G, Martin-Ventura JL, Hernandez-Vargas P, et al. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis. Arterioscler Thromb Vasc Biol 2009;29:525-531
11. Emanuelli B, Peraldi P, Filloux C, Sawka-Verhelle D, Hilton D, Van Obberghen E. SOCS-3 is an insulin-induced negative regulator of insulin signaling. J Biol Chem 2000;275:15985-15991 (Pubitemid 30366903)
12. Rui L, Yuan M, Frantz D, Shoelson S, White MF. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem 2002;277:42394-42398 (Pubitemid 35257562)
13. Foster GD, Wyatt HR, Hill JO, et al. A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med 2003;348:2082-2090 (Pubitemid 36583303)
14. Kirk JK, Graves DE, Craven TE, Lipkin EW, Austin M, Margolis KL. Restricted-carbohydrate diets in patients with type 2 diabetes: a metaanalysis. J Am Diet Assoc 2008;108:91-100 (Pubitemid 350296011)
15. Westman EC, Yancy WS Jr, Mavropoulos JC, Marquart M, McDuffie JR. The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus. Nutr Metab (Lond) 2008;5:36-44
16. Unger RH, Clark GO, Scherer PE, Orci L. Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochim Biophys Acta 2010;1801:209-214
17. Bar-Tana J, Ben-Shoshan S, Blum J, et al. Synthesis and hypolipidemic and antidiabetogenic activities of β,β,β',β'-tetrasubstituted, long-chain dioic acids. J Med Chem 1989;32:2072-2084 (Pubitemid 19224168)
18. Bar-Tana J, Rose-Kahn G, Frenkel B, Shafer Z, Fainaru M. Hypolipidemic effect of β, β'-methyl-substituted hexadecanedioic acid (MEDICA 16) in normal and nephrotic rats. J Lipid Res 1988;29:431-441
19. Mayorek N, Kalderon B, Itach E, Bar-Tana J. Sensitization to insulin induced by β,β'-methyl-substituted hexadecanedioic acid (MEDICA 16) in obese Zucker rats in vivo. Diabetes 1997;46:1958-1964 (Pubitemid 27512080)
20. Russell JC, Shillabeer G, Bar-Tana J, et al. Development of insulin resistance in the JCR:LA-cp rat: role of triacylglycerols and effects of MEDICA 16. Diabetes 1998;47:770-778 (Pubitemid 28201807)
21. Russell JC, Amy RM, Graham SE, Dolphin PJ, Wood GO, Bar-Tana J. Inhibition of atherosclerosis and myocardial lesions in the JCR:LA-cp rat by β, β'-tetramethylhexadecanedioic acid (MEDICA 16). Arterioscler Thromb Vasc Biol 1995;15:918-923
22. Za'tara G, Bar-Tana J, Kalderon B, et al. AMPK activation by long chain fatty acyl analogs. Biochem Pharmacol 2008;76:1263-1275
23. Kalderon B, Sheena V, Shachrur S, Hertz R, Bar-Tana J. Modulation by nutrients and drugs of liver acyl-CoAs analyzed by mass spectrometry. J Lipid Res 2002;43:1125-1132 (Pubitemid 34760884)
24. Szalai AJ, McCrory MA. Varied biologic functions of C-reactive protein: lessons learned from transgenic mice. Immunol Res 2002;26:279-287 (Pubitemid 35177504)
25. Zhang X, Gan L, Pan H, et al. Phosphorylation of serine 256 suppresses transactivation by FKHR (FOXO1) by multiple mechanisms. Direct and indirect effects on nuclear/cytoplasmic shuttling and DNA binding. J Biol Chem 2002;277:45276-45284 (Pubitemid 36159133)
26. Besser D, Bromberg JF, Darnell JE Jr, Hanafusa HA. A single amino acid substitution in the v-Eyk intracellular domain results in activation of Stat3 and enhances cellular transformation. Mol Cell Biol 1999;19:1401-1409 (Pubitemid 29046881)
27. Gan L, Zheng W, Chabot JG, Unterman TG, Quirion R. Nuclear/cytoplasmic shuttling of the transcription factor FoxO1 is regulated by neurotrophic factors. J Neurochem 2005;93:1209-1219 (Pubitemid 40776575)
28. Zinszner H, Kuroda M, Wang XZ, et al. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev 1998;12:982-995 (Pubitemid 28204605)
29. Sheena V, Hertz R, Berman I, Nousbeck J, Bar-Tana J. Transcriptional suppression of human microsomal triglyceride transfer protein by hypolipidemic insulin sensitizers. Biochem Pharmacol 2005;70:1548-1559 (Pubitemid 41540348)
30. Bronner M, Hertz R, Bar-Tana J. Kinase-independent transcriptional coactivation of peroxisome proliferator-activated receptor alpha by AMPactivated protein kinase. Biochem J 2004;384:295-305 (Pubitemid 39656242)
31. Weidenfeld-Baranboim K, Bitton-Worms K, Aronheim A. TRE-dependent transcription activation by JDP2-CHOP10 association. Nucleic Acids Res 2008;36:3608-3619 (Pubitemid 351917525)
32. Silverman E, Yivgi-Ohana N, Sher N, Bell M, Eimerl S, Orly J. Transcriptional activation of the steroidogenic acute regulatory protein (StAR) gene: GATA-4 and CCAAT/enhancer-binding protein β confer synergistic responsiveness in hormone-treated rat granulosa and HEK293 cell models. Mol Cell Endocrinol 2006;252:92-101
33. Fernandez ML. Guinea pigs as models for cholesterol and lipoprotein metabolism. J Nutr 2001;131:10-20 (Pubitemid 32060616)
34. Roberts RA. Peroxisome proliferators: mechanisms of adverse effects in rodents and molecular basis for species differences. Arch Toxicol 1999;73: 413-418 (Pubitemid 30010241)
35. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-2410 (Pubitemid 32269192)
36. Leite JO, DeOgburn R, Ratliff JC, et al. Low-carbohydrate diet disrupts the association between insulin resistance and weight gain. Metabolism 2009; 58:1116-1122
37. He G, Karin M. NF-κB and STAT3 - key players in liver inflammation and cancer. Cell Res 2011;21:159-168
38. Zhao X, Gan L, Pan H, et al. Multiple elements regulate nuclear/cytoplasmic shuttling of FOXO1: characterization of phosphorylation- and 14-3-3-dependent and -independent mechanisms. Biochem J 2004;378:839-849 (Pubitemid 38406861)
39. Dixit M, Bess E, Fisslthaler B, et al. Shear stress-induced activation of the AMP-activated protein kinase regulates FoxO1a and angiopoietin-2 in endothelial cells. Cardiovasc Res 2008;77:160-168 (Pubitemid 351195147)
40. Barthel A, Schmoll D, Krüger KD, Roth RA, Joost HG. Regulation of the forkhead transcription factor FKHR (FOXO1a) by glucose starvation and AICAR, an activator of AMP-activated protein kinase. Endocrinology 2002; 143:3183-3186 (Pubitemid 34809893)
41. Wang F, Marshall CB, Yamamoto K, et al. Biochemical and structural characterization of an intramolecular interaction in FOXO3a and its binding with p53. J Mol Biol 2008;384:590-603
42. Nerlov C. The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends Cell Biol 2007;17:318-324 (Pubitemid 47102200)
43. Milosavljeví T, Lazić T, Uskoković A, Petrović M, Grigorov I. Expression of the rat liver haptoglobin gene is mediated by isoforms of C/EBPalpha, -β and -δ proteins. Gen Physiol Biophys 2003;22:181-190 (Pubitemid 37304119)
44. Bogojević D, Mihailović M, Petrović M, Dinić S, Ivanović-Matić S, Poznanović G. Acute-phase-dependent binding affinity of C/EBPbeta from the nuclear extract and nuclear matrix towards the hormone response element of the alpha2-macroglobulin gene in rat hepatocytes. Gen Physiol Biophys 2003;22:279-285 (Pubitemid 37304128)
45. Christian M, Zhang X, Schneider-Merck T, et al. Cyclic AMP-induced forkhead transcription factor, FKHR, cooperates with CCAAT/enhancer-binding protein beta in differentiating human endometrial stromal cells. J Biol Chem 2002;277:20825-20832 (Pubitemid 34967389)
46. Tsai WC, Bhattacharyya N, Han LY, Hanover JA, Rechler MM. Insulin inhibition of transcription stimulated by the forkhead protein Foxo1 is not solely due to nuclear exclusion. Endocrinology 2003;144:5615-5622 (Pubitemid 37479310)
47. He L, Sabet A, Djedjos S, et al. Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein. Cell 2009;137:635-646
48. Foretz M, Hébrard S, Leclerc J, et al. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J Clin Invest 2010;120:2355-2369
49. Greer EL, Oskoui PR, Banko MR, et al. The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J Biol Chem 2007;282:30107-30119 (Pubitemid 350035296)
50. Gimeno RE, Cao J. Thematic review series: glycerolipids. Mammalian glycerol-3-phosphate acyltransferases: new genes for an old activity. J Lipid Res 2008;49:2079-2088